methylprednisolone sodium succinate · Pharmacia And Upjohn · NDA 011856

Solu-Medrol

Earliest generic entry, as listed · earliest of 5 marketed strengths
Open now

No unexpired patents or exclusivities are listed for this product.

Listed patents · 0 unexpired

No unexpired patents listed.

Exclusivities · 0 unexpired

No unexpired exclusivities listed.

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products covered · 5

NDA · productFormStrengthListed expiry
011856 · 003 · RLDinjectable, injectionEQ 40MG BASE/VIALopen
011856 · 004 · RLDinjectable, injectionEQ 125MG BASE/VIALopen
011856 · 005 · RLDinjectable, injectionEQ 500MG BASE/VIALopen
011856 · 006 · RLDinjectable, injectionEQ 1GM BASE/VIALopen
011856 · 007 · RLDinjectable, injectionEQ 2GM BASE/VIALopen